Records containing: Heartburn
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-13PepZinGI® Crossover Heartburn Clinical Study
-
CLINICAL_TRIALS study record update · 2026-04-13Treatment Protocol for the Compassionate Use of Domperidone
-
CLINICAL_TRIALS study record update · 2026-02-12Breath Testing for Small Intestinal Bacterial Overgrowth in Patients Treated With Proton Pump Inhibitors
-
CLINICAL_TRIALS study record update · 2025-05-31The Effect of the LEFT Smartwatch App as Sleep Positional Therapy for Nocturnal Gastroesophageal Reflux Symptoms.
-
CLINICAL_TRIALS study record update · 2025-05-22Vonoprazan Pregnancy Registry: An Observational Study of the Safety of Vonoprazan Exposure in Pregnant Women and Their Offspring
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-05-13Observational Study to Evaluate Effectiveness, Safety and Satisfaction Level of Zastaprazan (JAQBO®) Under Daily Treatment for Patients With Erosive Gastroesophageal Reflux Disease
-
CLINICAL_TRIALS study record update · 2025-03-25A Phase 1, Open-label Study to Evaluate Vonoprazan Concentrations in Breast Milk of Healthy Lactating Women Receiving Vonoprazan 20 mg Once Daily or Vonoprazan 20 mg Twice Daily
-
CLINICAL_TRIALS study record update · 2025-02-13Smartphone App-assisted Discontinuation of Short-term PPI Treatment - an Feasibility Study
-
CLINICAL_TRIALS study record update · 2025-01-31Determining the Optimal Strategy for Stopping Chronic Proton Pump Inhibitor Therapy in Primary Care Patients: Impact of On-demand Use, Adjunctive Therapies and Antacids
-
CLINICAL_TRIALS study record update · 2025-01-14Remote Guided Caffeine Reduction
-
CLINICAL_TRIALS study record update · 2024-08-14An Open-label, Randomized, Crossover Study to Investigate the Comparative Pharmacodynamics and Pharmacodynamics Equivalence of Antareit 800 Chewable Tablets and Riopan 800 mg Chewable Tablets in Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2024-07-22An Open-label, Randomized, Crossover Study to Investigate the Comparative Pharmacodynamics and Pharmacodynamics Equivalence of Antareit 800 mg/10 ml Oral Suspension and Riopan 800 mg Chewable Tablets in Healthy Volunteers.
-
CLINICAL_TRIALS study record update · 2024-07-03An Open Label, Single Center, Randomized, Two-way Crossover Parallel Group, Trial to Assess the Mechanism of Action of a Bi-layer Swallowable Tablet (Immediate Release and Sustained Release) Containing Calcium Carbonate Antacid in an Overnight and Day Application as Compared With a Standard, Non-layered (Immediate Release) Calcium Carbonate Swallow Tablet in Fed Healthy Male Participants.
-
CLINICAL_TRIALS study record update · 2023-12-29A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Vonoprazan 10 and 20 mg Compared to Placebo for Relief of Heartburn in Subjects With Symptomatic Non-Erosive Gastroesophageal Reflux Disease (NERD) After 4 Weeks and to Evaluate the Efficacy and Safety of Vonoprazan 10 and 20 mg for Relief of Heartburn in Subjects With NERD After 6 Months
-
CLINICAL_TRIALS study record update · 2023-12-07Implementation, Integration and Sustainability of a Minor Ailment Service in Usual Practice of Community Pharmacy
-
CLINICAL_TRIALS study record update · 2023-07-18A Parallel Randomized, Blinded, Un-controlled Tolerability Study of Panosyl-Isomaltooligosaccharides (PIMO) and a Placebo, in Subjects With Heartburn
-
CLINICAL_TRIALS study record update · 2023-06-13Prevalence of Fuctional Heartburn in Patients With IBS .
-
CLINICAL_TRIALS study record update · 2023-01-04A Phase 2, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Vonoprazan 10 mg, 20 mg, and 40 mg Compared to Placebo for Relief of Episodic Heartburn in Subjects With Symptomatic Non-Erosive Gastroesophageal Reflux Disease
-
CLINICAL_TRIALS study record update · 2022-10-25Prospective Study Assessing Patient Satisfaction of Symptom Control With Proton Pump Inhibitor Dosing Regimen
-
CLINICAL_TRIALS study record update · 2022-02-03Study of Dietary Patterns and Food Diversity in Russian GERD Patients
-
CLINICAL_TRIALS study record update · 2021-12-08Bile Reflux Gastropathy: Prevalence and Risk Factors After Therapeutic Biliary Interventions: A Retrospective Cohort Study
-
CLINICAL_TRIALS study record update · 2021-11-15Evaluation of the Impact of the HLNatural, Inc. Upset Stomach Relief Product on the Reduction of Symptoms in Adults Who Suffer From Mild to Moderate Indigestion and Heartburn
-
CLINICAL_TRIALS study record update · 2021-05-26Efficacy and Safety of Mipolixin® Compared to Poliprotect ® in the Relief of Symptoms of Moderate Functional Dyspepsia and Heartburn: A Randomized, Double-blind, Parallel Group,Non-inferiority Clinical Study
-
CLINICAL_TRIALS study record update · 2020-06-09The Effect of Fermented Soy Supplementation on Occasional Heartburn Symptom Relief: A Randomized, Placebo-Controlled, Double-blind Trial
-
CLINICAL_TRIALS study record update · 2019-07-05A Phase 3 Double-blind Study to Evaluate the Efficacy and Safety of Dexlansoprazole (30 mg QD) Compared to Placebo on Heartburn Relief in Subjects With Symptomatic Nonerosive Gastroesophageal Reflux Disease (GERD)